Quanterix Corp

Quanterix COO’s 4,500‑share buy signals confidence and hints at future upside amid new product launch and AACR buzz.

Quanterix insider trades reveal executive confidence: 33k+ RSUs & 113k options signal long‑term alignment, while COO and CFO actions highlight short‑term volatility.

Quanterix CFO insider trades signal confidence ahead of FDA‑submissions: modest buys and sells reveal a balanced liquidity strategy and potential upside for Alzheimer’s diagnostics.

Quanterix insider buying shows board confidence: Thomas’s RSU purchase signals long‑term upside in oncology and neurology diagnostics, urging investors to track regulatory milestones and pipeline progress.